A validation study of the new revised FIGO staging system to estimate prognosis for patients with stage IIIC endometrial cancer

Gynecologic Oncology

Volumn 121, Issue 1, 2011, Pages 126-130

  Todo, Yukiharu ^a   Kato, Hidenori ^a   Minobe, Shinichiro ^a   Okamoto, Kazuhira ^a   Suzuki, Yoshihiro ^a   Konno, Yosuke ^a   Takeda, Mahito ^b   Watari, Hidemichi ^b   Kaneuchi, Masanori ^b   Sakuragi, Noriaki ^b  

^a HOKKAIDO CANCER CENTER   (Japan)

^b HOKKAIDO UNIVERSITY   (Japan)

Author keywords

Endometrial cancer; Lymphadenectomy; Prognosis; Surgical staging

Indexed keywords

ANTINEOPLASTIC AGENT;

ADJUVANT THERAPY; ADULT; AGE; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER STAGING; CONTROLLED STUDY; ENDOMETRIUM CANCER; FEMALE; HEALTH CARE ORGANIZATION; HISTOPATHOLOGY; HUMAN; LYMPH NODE METASTASIS; LYMPHADENECTOMY; MAJOR CLINICAL STUDY; MEDICAL RECORD REVIEW; OVERALL SURVIVAL; PARAAORTIC LYMPH NODE; PELVIS LYMPH NODE; PRIORITY JOURNAL; PROGNOSIS; RISK FACTOR; VALIDATION STUDY;

AGED; CARCINOMA, ENDOMETRIOID; CHEMOTHERAPY, ADJUVANT; ENDOMETRIAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODE EXCISION; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; RADIOTHERAPY, ADJUVANT; REPRODUCIBILITY OF RESULTS; SURVIVAL RATE;

EID: 79952818182     PISSN: 00908258     EISSN: 10956859     Source Type: Journal    
DOI: 10.1016/j.ygyno.2010.12.001     Document Type: Article

References (10)

1. Creasman W. Revised FIGO staging for carcinoma of the endometrium. Int J Gynaecol Obstet 2009;105:109.
2. ASTEC study group. Efficacy of systematic pelvic lymphadenectomy in endometrial cancer (MRC ASTEC trial): a randomized study. Lancet 2009;373:125-36.
3. Benedetti- Panici P, Basile S, Maneschi F, et al. Systematic pelvic lymphadenectomy vs no lymphadenectomy in early-stage endometrial carcinoma: randomized clinical trial. J Natl Cancer Inst 2008;100:1707-16.
4. Todo Y, Kato H, Kaneuchi M, Watari H, Takeda M, Sakuragi N. Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis. Lancet 2010;375:1165-72.
5. Mariani A, Dowdy SC, Cliby WA, et al. Prospective assessment of lymphatic dissemination in endometrial cancer: a paradigm shift in surgical staging. Gynecol Oncol 2008;109:11-8.
6. Yokoyama Y, Maruyama H, Sato S, Saito Y. Indispensability of pelvic and paraaortic lymphadenectomy in endometrial cancers. Gynecol Oncol 1997;64:411-7. (Pubitemid 27120428)
7. Matsumoto K, Yoshikawa H, Yasugi T, Onda T, Nakagawa S, Yamada M, Kawana K, Minaguchi T, Oda K, Hasumi Y, Taketani Y. Distinct lymphatic spread of endometrial carcinoma in comparison with cervical and ovarian carcinomas. Cancer Lett 2002;180:83-9. (Pubitemid 34242968)
8. Burke TW, Levenback C, Tornos C, Morris M, Wharton JT, Gershenson DM. Intraabdominal lymphatic mapping to direct selective pelvic and paraaortic lymphadenectomy in woman with high-risk endometrial cancer: results of a pilot study. Gynecol Oncol 1996;62:169-73. (Pubitemid 26274795)
9. Niikura H, Okamura C, Utsunomiya H, Yoshinaga K, Akahira J, Ito K, Yaegashi N. Sentinel lymph node detection in patients with endometrial cancer. Gynecol Oncol 2004;92:669-74. (Pubitemid 38183161)
10. Raspagliesi F, Ditto A, Kusamura S, Fontanelli R, Vecchione F, Maccauro M, Solima E. Hysteroscopic injection of traces in sentinel node detection of endometrial cancer: a feasibility study. Am J Obstet Gynecol 2004;191:435-9. (Pubitemid 39178695)